AccessibilityHelp
HeartBeam logo

HeartBeam(NASDAQ) BEATW

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-98%
5 YearN/A
1 Year-96%
1 Month+34%
$0.01
+22.64%
+0.00Today
HeartBeam last closing stock price
MetricPriceDate
Last closeUSD 0.012026-10-23
HeartBeam stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+319.35%USD 0.002026-10-16
1 month+34.02%USD 0.012026-09-23
3 month-47.79%USD 0.022026-07-24
Year to date-95.94%USD 0.322025-12-31
1 year-95.51%USD 0.292025-10-23
3 year-95%USD 0.262023-10-19
Since inception-98.49%USD 0.862021-11-11

HeartBeam Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$0.00

Net Income (TTM)

-$20.30M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$0.01

Volume

39,696

Open

$0.02

Previous Close

$0.01

Daily Range

$0.01 - $0.02

52-Week Range

$0.00 - $0.56

Estimated Earnings Date

Nov 5, 2026

BEATW News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HeartBeam

HeartBeam, Inc. is an innovative company focused on advancing cardiovascular diagnostic technology. The firm has developed a unique electrocardiogram (ECG) device that allows for remote monitoring of heart health, enabling healthcare professionals to access critical data outside traditional clinical settings.

Products and Services
  • Remote ECG collection device for heart health monitoring
  • Cloud-based software for real-time data analysis
  • Innovative solutions aimed at improving cardiovascular diagnostics
Growth Outlook
  • Significant market potential in remote healthcare diagnostics
  • Increasing demand for telehealth solutions post-pandemic
  • Strategic partnerships may enhance product distribution and reach
Financial Highlights
  • Recent quarterly net income of -$5.04 million, reflecting ongoing investment in R&D
  • Cash and cash equivalents of $8.72 million as of June 30, 2026
  • Current ratio of 3.66 indicates strong liquidity position
HeartBeam, Inc. operates in the healthcare sector, specifically within medical specialties, and is headquartered in Santa Clara, California. The company was founded in 2015 by Branislav Vajdic and has since focused on developing cutting-edge technology to improve cardiovascular health monitoring. The ECG device transmits data wirelessly to a smartphone, which then sends the information to a cloud-based system for analysis, allowing for timely medical insights. The growth outlook for HeartBeam is promising, driven by the increasing demand for remote healthcare solutions, particularly in the wake of the COVID-19 pandemic. The company's innovative approach positions it well to capitalize on the expanding telehealth market. Additionally, potential strategic partnerships could further enhance its market presence and distribution capabilities. Financially, HeartBeam has shown a commitment to investing in research and development, as evidenced by its recent quarterly net income figures. The company maintains a solid liquidity position, with a current ratio indicating it can cover its short-term liabilities comfortably. With a focus on innovation and a growing market, HeartBeam, Inc. presents an intriguing opportunity for investors interested in the healthcare technology sector.
AI Generated • Oct 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Headquarters

Santa Clara, CA 95050, US

BEATW Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-686.78%

Return on Capital

-812.10%

Return on Assets

-190.81%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

0

Volume

39.70K

Avg. Volume

47.30K

Financials (TTM)

Gross Profit

-$24.00K

Operating Income

-$20.41M

EBITDA

-$20.24M

Operating Cash Flow

-$13.02M

Capital Expenditure

-$993.00K

Free Cash Flow

-$14.01M

Cash & ST Invst.

$8.72M

Total Debt

$0.00

HeartBeam Performance Analysis

HeartBeam sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-31N/A
Q22026-06-30N/A
HeartBeam sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31N/A
Q12026-03-3120.0%
Q22026-06-3016.7%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

16

N/A

Net Income

-$5.04M

-1.3%

EBITDA

-$5.04M

-1.4%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$8.72M

+72.6%

Total Debt

$0.00

N/A

Accounts Receivable

$0.00

N/A

Inventory

$110.00K

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-1.91%

N/A

Return on Invested Capital

-2.50%

N/A

Free Cash Flow

-$3.59M

-1.2%

Operating Cash Flow

-$3.34M

+3.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
KZRKezar Life Sciences, Inc.
$7.29+0.00%
FGENFibroGen, Inc.
$9.07-1.63%
NOTVInotiv, Inc.
$0.08+121.94%
TPSTTempest Therapeutics, Inc.
$0.51-2.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
HYGiShares Trust - iShares iBoxx $ High Yieldorate Bond ETF
$77.05-0.07%
EWZiShares - iShares Msci Brazil ETF
$42.59+1.77%
NUNu Holdings
$15.16+2.92%
SOXLDirexion Shares ETF Trust - Direxion Daily Semiconductor Bull 3x ETF
$83.56+1.77%

Questions About BEATW

What is the current price of HeartBeam?

HeartBeam is trading at $0.01 per share.

What is the 52-week range for HeartBeam?

Over the past 52 weeks, HeartBeam has traded between $0.00 and $0.56.

How much debt does HeartBeam have?

HeartBeam total debt is unavailable.

How much cash does HeartBeam have on hand?

HeartBeam does not have cash on hand data available.

What is HeartBeam’s dividend yield?

HeartBeam does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services